| Dr Nathaniel S Rial, MD/PHD/MPH | |
|
Naval Hospital, 100 Brewster Blvd, Apo, AA 28547-2538 | |
| (910) 450-4159 | |
| (910) 450-4194 |
| Full Name | Dr Nathaniel S Rial |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 15 Years |
| Location | Naval Hospital, Apo, Armed Forces Americas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750510327 | NPI | - | NPPES |
| R71672 | Other | AZ | ARIZONA MEDICAL BOARD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | R71672 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph's Hospital | Tucson, AZ | Hospital |
| St. Mary's Hospital | Tucson, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cogent Healthcare Of Arizona Pc | 0648441006 | 66 |
News Archive
Recently, it has been demonstrated that Transcatheter arterial chemoembolization (TACE) improves survival compared with best supportive care in meta-analyses of randomized trials and in two individual clinical trials.
Retail health clinics are reevaluating their offerings. The Wall Street Journal reports: "Retail health clinics are adding treatments for chronic diseases such as asthma to their repertoire, hoping to find steadier revenue, but putting the clinics into greater competition with doctors' groups and hospitals."
The largest and longest running study of children born after preimplantation genetic diagnosis and screening has shown that embryo biopsy does not adversely affect the health of babies born as the result of a subsequent singleton pregnancy.
Senesco Technologies, Inc. today announced the initiation of patient dosing in its Phase 1b/2a clinical study of SNS01-T at the Mayo Clinic in Rochester, MN. The study is an open-label, multiple-dose, dose-escalation study which will evaluate the safety and tolerability of SNS01-T when administered by intravenous infusion to relapsed or refractory multiple myeloma patients.
› Verified 7 days ago
| Entity Name | American Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609869908 PECOS PAC ID: 3577467463 Enrollment ID: O20031121000688 |
News Archive
Recently, it has been demonstrated that Transcatheter arterial chemoembolization (TACE) improves survival compared with best supportive care in meta-analyses of randomized trials and in two individual clinical trials.
Retail health clinics are reevaluating their offerings. The Wall Street Journal reports: "Retail health clinics are adding treatments for chronic diseases such as asthma to their repertoire, hoping to find steadier revenue, but putting the clinics into greater competition with doctors' groups and hospitals."
The largest and longest running study of children born after preimplantation genetic diagnosis and screening has shown that embryo biopsy does not adversely affect the health of babies born as the result of a subsequent singleton pregnancy.
Senesco Technologies, Inc. today announced the initiation of patient dosing in its Phase 1b/2a clinical study of SNS01-T at the Mayo Clinic in Rochester, MN. The study is an open-label, multiple-dose, dose-escalation study which will evaluate the safety and tolerability of SNS01-T when administered by intravenous infusion to relapsed or refractory multiple myeloma patients.
› Verified 7 days ago
| Entity Name | Cogent Healthcare Of Arizona Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568758266 PECOS PAC ID: 0648441006 Enrollment ID: O20110915000843 |
News Archive
Recently, it has been demonstrated that Transcatheter arterial chemoembolization (TACE) improves survival compared with best supportive care in meta-analyses of randomized trials and in two individual clinical trials.
Retail health clinics are reevaluating their offerings. The Wall Street Journal reports: "Retail health clinics are adding treatments for chronic diseases such as asthma to their repertoire, hoping to find steadier revenue, but putting the clinics into greater competition with doctors' groups and hospitals."
The largest and longest running study of children born after preimplantation genetic diagnosis and screening has shown that embryo biopsy does not adversely affect the health of babies born as the result of a subsequent singleton pregnancy.
Senesco Technologies, Inc. today announced the initiation of patient dosing in its Phase 1b/2a clinical study of SNS01-T at the Mayo Clinic in Rochester, MN. The study is an open-label, multiple-dose, dose-escalation study which will evaluate the safety and tolerability of SNS01-T when administered by intravenous infusion to relapsed or refractory multiple myeloma patients.
› Verified 7 days ago
| Entity Name | Hospitalist Medicine Physicians Of Arizona - Tucson Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629557798 PECOS PAC ID: 7113279886 Enrollment ID: O20181008001135 |
News Archive
Recently, it has been demonstrated that Transcatheter arterial chemoembolization (TACE) improves survival compared with best supportive care in meta-analyses of randomized trials and in two individual clinical trials.
Retail health clinics are reevaluating their offerings. The Wall Street Journal reports: "Retail health clinics are adding treatments for chronic diseases such as asthma to their repertoire, hoping to find steadier revenue, but putting the clinics into greater competition with doctors' groups and hospitals."
The largest and longest running study of children born after preimplantation genetic diagnosis and screening has shown that embryo biopsy does not adversely affect the health of babies born as the result of a subsequent singleton pregnancy.
Senesco Technologies, Inc. today announced the initiation of patient dosing in its Phase 1b/2a clinical study of SNS01-T at the Mayo Clinic in Rochester, MN. The study is an open-label, multiple-dose, dose-escalation study which will evaluate the safety and tolerability of SNS01-T when administered by intravenous infusion to relapsed or refractory multiple myeloma patients.
› Verified 7 days ago
| Entity Name | Hospitalist Medicine Physicians Of Arizona - Goodyear, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790264802 PECOS PAC ID: 1951653187 Enrollment ID: O20181016002244 |
News Archive
Recently, it has been demonstrated that Transcatheter arterial chemoembolization (TACE) improves survival compared with best supportive care in meta-analyses of randomized trials and in two individual clinical trials.
Retail health clinics are reevaluating their offerings. The Wall Street Journal reports: "Retail health clinics are adding treatments for chronic diseases such as asthma to their repertoire, hoping to find steadier revenue, but putting the clinics into greater competition with doctors' groups and hospitals."
The largest and longest running study of children born after preimplantation genetic diagnosis and screening has shown that embryo biopsy does not adversely affect the health of babies born as the result of a subsequent singleton pregnancy.
Senesco Technologies, Inc. today announced the initiation of patient dosing in its Phase 1b/2a clinical study of SNS01-T at the Mayo Clinic in Rochester, MN. The study is an open-label, multiple-dose, dose-escalation study which will evaluate the safety and tolerability of SNS01-T when administered by intravenous infusion to relapsed or refractory multiple myeloma patients.
› Verified 7 days ago
| Entity Name | Hospitalist Medicine Physicians Of Arizona - Tcs |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538758909 PECOS PAC ID: 3274940028 Enrollment ID: O20210324000655 |
News Archive
Recently, it has been demonstrated that Transcatheter arterial chemoembolization (TACE) improves survival compared with best supportive care in meta-analyses of randomized trials and in two individual clinical trials.
Retail health clinics are reevaluating their offerings. The Wall Street Journal reports: "Retail health clinics are adding treatments for chronic diseases such as asthma to their repertoire, hoping to find steadier revenue, but putting the clinics into greater competition with doctors' groups and hospitals."
The largest and longest running study of children born after preimplantation genetic diagnosis and screening has shown that embryo biopsy does not adversely affect the health of babies born as the result of a subsequent singleton pregnancy.
Senesco Technologies, Inc. today announced the initiation of patient dosing in its Phase 1b/2a clinical study of SNS01-T at the Mayo Clinic in Rochester, MN. The study is an open-label, multiple-dose, dose-escalation study which will evaluate the safety and tolerability of SNS01-T when administered by intravenous infusion to relapsed or refractory multiple myeloma patients.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nathaniel S Rial, MD/PHD/MPH 100 Brewster Blvd, Naval Hospital, Camp Lejeune, NC 28547-2538 Ph: (910) 450-4159 | Dr Nathaniel S Rial, MD/PHD/MPH Naval Hospital, 100 Brewster Blvd, Apo, AA 28547-2538 Ph: (910) 450-4159 |
News Archive
Recently, it has been demonstrated that Transcatheter arterial chemoembolization (TACE) improves survival compared with best supportive care in meta-analyses of randomized trials and in two individual clinical trials.
Retail health clinics are reevaluating their offerings. The Wall Street Journal reports: "Retail health clinics are adding treatments for chronic diseases such as asthma to their repertoire, hoping to find steadier revenue, but putting the clinics into greater competition with doctors' groups and hospitals."
The largest and longest running study of children born after preimplantation genetic diagnosis and screening has shown that embryo biopsy does not adversely affect the health of babies born as the result of a subsequent singleton pregnancy.
Senesco Technologies, Inc. today announced the initiation of patient dosing in its Phase 1b/2a clinical study of SNS01-T at the Mayo Clinic in Rochester, MN. The study is an open-label, multiple-dose, dose-escalation study which will evaluate the safety and tolerability of SNS01-T when administered by intravenous infusion to relapsed or refractory multiple myeloma patients.
› Verified 7 days ago
Dr. Gregory John Martin, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: Us Nmrcd - Peru; American Embassy, Unit 3800, Apo, AA 34031 Phone: 011-511-5623848 Fax: 011-511-5623848 | |
Michael Edward Nesemann, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: Unit 3755, Apo, AA 34031 Phone: 202-663-1662 | |
Dr. Georges Ferron Mccormick, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: Unit 3120, Us Embassy San Salvador, Apo, AA 34023 Phone: 011-503-25012550 Fax: 011-503-22282805 |